Lipid nano spheres (LNSs) for enhanced oral bioavailability of amphotericin B: Development and characterization

Journal of Biomedical Nanotechnology

Volumn 3, Issue 3, 2007, Pages 264-269

  Amarji, Basant ^a   Ajazuddin, ^a   Raghuwanshi, Dharmendra ^a   Vyas, S P ^a   Kanaujia, Parijat ^b  

^a DR H S GOUR UNIVERSITY   (India)

^b Strides Arcolab Limited   (India)

Author keywords

Amphotericin B; Lipid nano spheres; Oral bioavailability

Indexed keywords

AMPHOTERICIN B; MONOACYLGLYCEROL; NANOSPHERE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISPERSION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RELEASE; DRUG RESPONSE; DRUG SOLUBILITY; FEMALE; GASTROINTESTINAL ABSORPTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MALE; NANOPHARMACEUTICS; NONHUMAN; PEYER PATCH; RAT STRAIN; RESPONSE TIME; SINGLE DRUG DOSE;

EID: 45849094442     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2007.029     Document Type: Article

References (19)

1. M. S. Maddux and S. L. Barrieres, A review of complications of amphotericin-B therapy: Recommendations for prevention and management. Drug Intell. Clin. Pharm. 14, 177 (1980).
2. H. A. Gallis, R. H. Drew, and W. W. Pickard, Amphotericin B: 30 years of clinical experience. Ref. Infect Dis. 12, 308 (1990).
3. C. Gates and R. J. Pinney, Amphotericin B and its delivery by lipsomal and lipid formulations. J. Clin. Pharm. Ther. 18, 147 (1993).
4. K. M. Wasan, A. L. Kennedy, S. M. Cassidy, M. Ramasway, L. Holtorf, J. W. L. Chou, and P. H. Pritchard, Pharmacokinetics, distribution in serum lipoproteins and tissues, and renal toxicities of amphotericin B and amphotericin B lipid complex in a hypercholesterolemic rabbit model: Single-dose studies. Antimicrob. Agents Chemother. 42, 3146 ( 1998).
5. D. A. Stevens, Oral amphotericin B as an antifungal agent. J. Mycol. Med. 6(Suppl. II), 1 (1996).
6. S. Arikan and J. H. Rex, Lipid-based antifungal agents: Current status. Curr. Pharm. Des. 7, 393 (2001).
7. V. Risovic, M. Boyd, E. Choo, and K. M. Wasan, Effects of lipid-based oral formulations on plasma and tissue amphotericin B concentrations and renal toxicity in male rats. Antimicrob. Agents Chemother. 47, 3339 (2003).
8. J. S. Dangi, S. P. Vyas, and V. K. Dixit, Effect of various lipid-bile salt mixed micelles on the intestinal absorption of amphotericin-B in rat. Drug Dev. Ind. Pharm. 24, 631 (1998).
9. R. Santangelo, P. Paderu, G. Delmas, Z. W. Chen, R. Mannino, L. Zarif, and D. S. Perlin, Efficacy of oral cochleate-amphotericin B in a mouse model of systemic candidiasis. Antimicrob. Agents Chemother. 44, 2356 (2000).
10. G. Delmas, S. Park, Z. W. Chen, F. Tan, R. Kashiwazaki, L. Zarif, and D. S. Perlin, Efficacy of orally delivered cochleates containing amphotericin B in a murine model of aspergillosis. Antimicrob. Agents Chemother. 46, 2704 (2002).
11. R. Cortesi, E. Esposito, G. Luca, and C. Nastruzzi, Production of lipospheres as carriers for bioactive compounds. Biomaterial 23, 2283 (2002).
12. I. Gurda, P. Nadeau, J. Brajtburg, and G. Medoff, Application of differential spectra in the UV-Vis region to study the formation of amphotericin-B sterol complexes. Biochim. Biophy. Acta 602, 260 (1980).
13. M. Rodriguez, J. L. Vila-Jato, and D. Torres, Design of a new multi particulate system for potential site specific and controlled drug delivery to the colonic region. J. Control. Release 55, 67 ( 1998).
14. T. T. Kararli, Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm. Drug Dispos. 16, 351 (1995).
15. I. Echevarria, C. Barturen, M. J. Renedo, and M. C. Dios-vieitez, High-performance liquid chromatographic determination of amphotericin B in plasma and tissue: Application to pharmacokinetic and tissue distribution studies in rats. J. Chromatogr. A 819, 171 (1998).
16. L. Soria and C. L. Zimmeran, The validation of the intestinal permeability approach to predict oral fraction of dose absorbed in humans and rats. Biopharm. Drug Dispos. 17, 817 (1996).
17. C. J. Porter and W. N. Charman, Intestinal lymphatic drug transport: An update. Adv. Drug Delivery Rev. 50, 61 (2001).
18. L. C. Souza, R. C. Maranhao, S. Schreier, and A. Campa, In-vitro and in-vivo studies of the decrease of amphotericin B toxicity upon association with a triglyceride-rich emulsion. J. Antimicrob. Chemother. 32, 123 (1992).
19. N. Hussain, V. Jaitley, and A. T. Florence, Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. Adv. Drug Deliv. Rev. 50, 107 (2001).